The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology of Schizophrenia: A Review of the Evidence.

MLA

Clark, Samuel David, and Anissa Abi-Dargham. “The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology of Schizophrenia: A Review of the Evidence.” Biological Psychiatry, vol. 86, no. 7, Oct. 2019, pp. 502–11. EBSCOhost, https://doi.org/10.1016/j.biopsych.2019.05.012.

APA

Clark, S. D., & Abi-Dargham, A. (2019). The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology of Schizophrenia: A Review of the Evidence. Biological Psychiatry, 86(7), 502–511. https://doi.org/10.1016/j.biopsych.2019.05.012

Chicago

Clark, Samuel David, and Anissa Abi-Dargham. 2019. “The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology of Schizophrenia: A Review of the Evidence.” Biological Psychiatry 86 (7): 502–11. doi:10.1016/j.biopsych.2019.05.012.